UPLC–QToF–MS/MS screening and characterization of Symphorema polyandrum Wight and in vitro assessment of its antioxidant, anticancer, and anti-inflammatory potential
3 Biotech · 2024-12 · 14 (12)
DOI: 10.1007/s13205-024-04144-x ↗Kurz gefasst
Fachartikel in der Zeitschrift 3 Biotech, online erschienen am 12.11.2024. Verfasst von Dibya Ranjan Sahoo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre of Excellence in Natural Products and Therapeutics, Department of Biotechnology and Bioinformatics, Sambalpur University, Jyoti Vihar, Burla, …. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Symphorema polyandrum belongs to the Lamiaceae family and is locally known as Badichang or mahasindhu. In this study, we performed Soxhlet extraction to prepare methanolic and hydromethanolic extracts, followed by quantification of their total phenolic content and total flavonoid content. Qualitative analysis of both the extracts was conducted to determine the presence of different phytochemicals. In addition, we aimed to identify the important phytochemical constituents in the methanolic extracts of S. polyandrum (SPM) using ultra-performance liquid chromatography hyphenated with high-resolution mass spectrometry (UPLC-ESI-QTOF-MSE). Furthermore, this study investigated the antioxidant, anticancer and anti-inflammatory properties of SPM and its safety profile in the normal fibroblast cell line L929. A colony proliferation assay and a Griess assay were performed to evaluate the effects of SPM on colony formation and nitric oxide (NO) production. A total of 13 important phytochemicals were identified and reported. The methanolic extract of SPM demonstrated significant antioxidant activity. SPM also showed substantial antiproliferative activity on MDA-MB-231 triple-negative breast cancer cells, with an IC50 value of 45.53 ± 1.63 µg/ml, and also reduced the survival of these cancer cells by promoting nuclear fragmentation and condensation without causing harm to normal cells. SPM inhibits the colony formation and reduces the nitric oxide (NO) production. The anti-inflammatory potential of SPM was assessed utilizing the murine alveolar macrophages (J774.A.1) as an in vitro model, and SPM effectively lowered the levels of proinflammatory cytokines such as TNF-α and IL-6. These findings emphasized the antiproliferative potential of SPM to cancer cells, along with its anti-inflammatory, and antioxidant capabilities, indicating the therapeutic efficacy of this medicinal plant.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre of Excellence in Natural Products and Therapeutics, Department of Biotechnology and Bioinformatics, Sambalpur University, Jyoti Vihar, Burla, Sambalpur, Odisha 768 019 India.
- Waters India Private Limited, Unit No. 902, 9th Floor, Merlin Infinite, DN 51, Sector-V, Salt Lake City, Kolkata, West Bengal 700091 India.
ORCID-Profile: Pradeep Kumar Naik
Zitieren
APA
Sahoo, D. R., Babu, S. K., Naik, B. B., Hota, S. S., Bhoi, N., Sarkar, B., Ali, S. K. M., & Naik, P. K. (2024). UPLC–QToF–MS/MS screening and characterization of Symphorema polyandrum Wight and in vitro assessment of its antioxidant, anticancer, and anti-inflammatory potential. 3 Biotech, 14(12). https://doi.org/10.1007/s13205-024-04144-x
Vancouver
Sahoo DR, Babu SK, Naik BB, Hota SS, Bhoi N, Sarkar B, et al. UPLC–QToF–MS/MS screening and characterization of Symphorema polyandrum Wight and in vitro assessment of its antioxidant, anticancer, and anti-inflammatory potential. 3 Biotech. 2024;14(12). doi:10.1007/s13205-024-04144-x
BibTeX
@article{Sahoo2024,
author = {Sahoo, Dibya Ranjan and Babu, Swaraj Kumar and Naik, Baishali Basundhara and Hota, Sajna Sameekshya and Bhoi, Namita and Sarkar, Barun and Ali, S K Mustaq and Naik, Pradeep Kumar},
title = {UPLC–QToF–MS/MS screening and characterization of Symphorema polyandrum Wight and in vitro assessment of its antioxidant, anticancer, and anti-inflammatory potential},
journal = {3 Biotech},
year = {2024},
volume = {14},
number = {12},
doi = {10.1007/s13205-024-04144-x}
}
EUVIMED